1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Algeria Pharmaceuticals and Healthcare Report Q4 2016

Algeria Pharmaceuticals and Healthcare Report Q4 2016

  • August 2016
  • -
  • Business Monitor International
  • -
  • 91 pages

Includes 3 FREE quarterly updates



BMI View:
Algeria's large and growing healthcare and pharmaceutical market will continue to driveinterest from multinational drugmakers over the forecast period. Meanwhile, Algeria's pharmaceuticalexports will continue to expand as the country gradually strengthens its position as a key drugmanufacturing hub in the Middle East and Africa region. Import restrictions and market access barriers areset to benefit drugmakers that engage in domestic production or joint ventures with local manufacturers,although the Algerian market will remain dependent on imported high-end pharmaceuticals given limitedlocal production capacity for these products.

Headline Expenditure Projections


- Pharmaceuticals: DZD411.62bn (USD4.10bn) in 2015 to DZD440.26bn (USD4.02bn) in 2016; +7.0%in local currency and -2.0% in US dollar terms. Forecast revised downwards from last quarter.

- Healthcare: DZD1.21trn (USD12.09bn) in 2015 to DZD1.29trn (USD11.84bn) in 2016; +6.9% in localcurrency and -2.1% in US dollar terms. Forecast revised upwards from last quarter.

Table Of Contents

Algeria Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Algeria 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Algeria 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Algeria 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Algeria 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Algeria 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Algeria 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Algeria 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Algeria 2012-2020) 23
OTC Medicine Market Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Algeria 2012-2020) 25
Pharmaceutical Trade Forecast 26
Table: Pharmaceutical Trade Data And Forecasts (Algeria 2014-2020) 27
Table: Pharmaceutical Trade Data And Forecasts local currency (Algeria 2014-2020) 28
Industry Risk/Reward Index 29
Middle East and Africa Risk/Reward Index - Q4 2016 29
Algeria Risk/Reward Index 37
Rewards 37
Risks 38
Market Overview 39
Healthcare Sector 40
Research and Development 42
Clinical Trials 44
Epidemiology 45
Regulatory Review 48
Intellectual Property Issues 53
Pricing Regime 55
Reimbursement Regime 56
Competitive Landscape 57
Research-Based Industry 57
Table: Multinational Market Activity 59
Generic Drugmakers 60
Pharmaceutical Distribution 62
Pharmaceutical Retail 62
Company Profile 64
GlaxoSmithKline 64
Groupe Saidal 66
Merck and Co 70
Novartis 72
Pfizer 74
Sanofi 76
Demographic Forecast 80
Demographic Outlook 80
Table: Population Headline Indicators (Algeria 1990-2025) 81
Table: Key Population Ratios (Algeria 1990-2025) 81
Table: Urban/Rural Population and Life Expectancy (Algeria 1990-2025) 82
Table: Population By Age Group (Algeria 1990-2025) 82
Table: Population By Age Group % (Algeria 1990-2025) 83
Glossary 85
Methodology 87
Pharmaceutical Expenditure Forecast Model 87
Healthcare Expenditure Forecast Model 87
Notes On Methodology 88
Risk/Reward Index Methodology 89
Index Overview 90
Table: Pharmaceutical Risk/Reward Index Indicators 90
Indicator Weightings 91

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.